ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Topology-Aware Deep Learning on Higher-Order Structures for Drug Response Prediction.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multiscale higher-order molecular simplicial complex embedding for drug response prediction.Bioinformatics (Oxford, England) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Accurate prediction of anticancer drug response remains a central challenge in precision oncology. Existing approaches often rely on pairwise modeling, overlooking higher-order dependencies among drugs and cell lines. We present TopDr, a topology-aware deep learning framework that encodes both drugs and cell lines as multiscale simplicial complexes, capturing interactions at the 0-, 1-, and 2-simplex levels. By jointly integrating local higher-order neighborhoods and global topological structures, TopDr generates enriched representations for sensitivity prediction. Across six benchmark datasets, TopDr consistently matches or surpasses state-of-the-art baselines in both regression and classification tasks. Beyond predictive accuracy, TopDr offers mechanism-level interpretability: attention over 1- and 2-simplices highlights drug pairs and triplets with significant pathway enrichment, while cell line groupings reveal biologically coherent expression modules. These results demonstrate that modeling multiscale higher-order topology yields predictions that are not only accurate and robust but also biologically interpretable, paving the way for more reliable drug response modeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.